Abstract
OBJECTIVES—To evaluate serial central motor conduction time in the Miller Fisher syndrome. METHOD—Three patients with classic Miller Fisher syndrome were evaluated clinically. They had serial central motor conduction times measured with transcranial magnetic stimulation and nerve conduction studies. Motor evoked potentials were recorded from the first dorsal interossei and abductor hallucis muscles. RESULTS—All three patients showed reduction in central motor conduction times in tandem with gradual clinical improvement at each review. CONCLUSIONS—There is electrophysiological evidence of a central reversible corticospinal tract conduction abnormality in the Miller Fisher syndrome.
Full Text
The Full Text of this article is available as a PDF (120.0 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Al-Din A. N., Anderson M., Bickerstaff E. R., Harvey I. Brainstem encephalitis and the syndrome of Miller Fisher: a clinical study. Brain. 1982 Sep;105(Pt 3):481–495. doi: 10.1093/brain/105.3.481. [DOI] [PubMed] [Google Scholar]
- Barontini F., Di Lollo S., Maurri S., Lambruschini P. Localization of the pathological process in Miller Fisher syndrome. Ital J Neurol Sci. 1992 Apr;13(3):221–225. doi: 10.1007/BF02224393. [DOI] [PubMed] [Google Scholar]
- Berger A. R., Logigian E. L., Shahani B. T. Reversible proximal conduction block underlies rapid recovery in Guillain-Barré syndrome. Muscle Nerve. 1988 Oct;11(10):1039–1042. doi: 10.1002/mus.880111005. [DOI] [PubMed] [Google Scholar]
- Cowan J. M., Rothwell J. C., Dick J. P., Thompson P. D., Day B. L., Marsden C. D. Abnormalities in central motor pathway conduction in multiple sclerosis. Lancet. 1984 Aug 11;2(8398):304–307. doi: 10.1016/s0140-6736(84)92683-7. [DOI] [PubMed] [Google Scholar]
- Fantin A., Valenzuela R., Luco C., Vicuña X., Schweitzer M. Potenciales evocados auditivos en el síndrome de Fisher. Caso clínico. Rev Med Chil. 1991 Jul;119(7):798–802. [PubMed] [Google Scholar]
- Farah S., Khuraibet A. J., Montaser M. A., Hussain H. M. Miller Fisher syndrome: unique involvement of ophthalmic division of trigeminal nerve. Clin Neurol Neurosurg. 1995 Nov;97(4):328–331. doi: 10.1016/0303-8467(95)00055-o. [DOI] [PubMed] [Google Scholar]
- Giroud M., Mousson C., Chalopin J. M., Rifle G., Dumas R. Miller-Fisher syndrome and pontine abnormalities on MRI: a case report. J Neurol. 1990 Dec;237(8):489–490. doi: 10.1007/BF00314769. [DOI] [PubMed] [Google Scholar]
- Goldberg-Stern H., Melamed E., Gadoth N. Abnormal evoked potentials in Miller-Fisher syndrome: further evidence of combined peripheral and central demyelination. J Neurol Neurosurg Psychiatry. 1994 Apr;57(4):506–506. doi: 10.1136/jnnp.57.4.506. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hansen L. A., Galasko D. Lewy body disease. Curr Opin Neurol Neurosurg. 1992 Dec;5(6):889–894. [PubMed] [Google Scholar]
- Hatanaka T., Higashino H., Yasuhara A., Kobayashi Y. Miller Fisher syndrome: etiological significance of serial blink reflexes and MRI study. Electromyogr Clin Neurophysiol. 1992 Jun;32(6):317–319. [PubMed] [Google Scholar]
- Hughes R. A., Rees J. H. Guillain-Barré syndrome. Curr Opin Neurol. 1994 Oct;7(5):386–392. doi: 10.1097/00019052-199410000-00004. [DOI] [PubMed] [Google Scholar]
- Inoue A., Koh C., Iwahashi T. Detection of serum anticerebellar antibodies in patients with Miller Fisher syndrome. Eur Neurol. 1999;42(4):230–234. doi: 10.1159/000008113. [DOI] [PubMed] [Google Scholar]
- Jamal G. A., Ballantyne J. P. The localization of the lesion in patients with acute ophthalmoplegia, ataxia and areflexia (Miller Fisher syndrome). A serial multimodal neurophysiological study. Brain. 1988 Feb;111(Pt 1):95–114. doi: 10.1093/brain/111.1.95. [DOI] [PubMed] [Google Scholar]
- Jamal G. A., MacLeod W. N. Electrophysiologic studies in Miller Fisher syndrome. Neurology. 1984 May;34(5):685–688. doi: 10.1212/wnl.34.5.685. [DOI] [PubMed] [Google Scholar]
- Kusunoki S. [Antiganglioside antibodies in the pathogenesis of autoimmune neuropathies]. Rinsho Shinkeigaku. 1999 Jan;39(1):93–95. [PubMed] [Google Scholar]
- Kuwabara S., Yuki N., Koga M., Hattori T., Matsuura D., Miyake M., Noda M. IgG anti-GM1 antibody is associated with reversible conduction failure and axonal degeneration in Guillain-Barré syndrome. Ann Neurol. 1998 Aug;44(2):202–208. doi: 10.1002/ana.410440210. [DOI] [PubMed] [Google Scholar]
- Litvan I., MacIntyre A., Goetz C. G., Wenning G. K., Jellinger K., Verny M., Bartko J. J., Jankovic J., McKee A., Brandel J. P. Accuracy of the clinical diagnoses of Lewy body disease, Parkinson disease, and dementia with Lewy bodies: a clinicopathologic study. Arch Neurol. 1998 Jul;55(7):969–978. doi: 10.1001/archneur.55.7.969. [DOI] [PubMed] [Google Scholar]
- Maier H., Schmidbauer M., Pfausler B., Schmutzhard E., Budka H. Central nervous system pathology in patients with the Guillain-Barré syndrome. Brain. 1997 Mar;120(Pt 3):451–464. doi: 10.1093/brain/120.3.451. [DOI] [PubMed] [Google Scholar]
- Mizoguchi K. Anti-GQ1b IgG antibody activities related to the severity of Miller Fisher syndrome. Neurol Res. 1998 Oct;20(7):617–624. doi: 10.1080/01616412.1998.11740573. [DOI] [PubMed] [Google Scholar]
- Nagaoka U., Kato T., Kurita K., Arawaka S., Hosoya T., Yuki N., Shikama Y., Yamaguchi K., Sasaki H. Cranial nerve enhancement on three-dimensional MRI in Miller Fisher syndrome. Neurology. 1996 Dec;47(6):1601–1602. doi: 10.1212/wnl.47.6.1601. [DOI] [PubMed] [Google Scholar]
- Pedotti R., Carpo M., Lucchi S., Righini A., Scarlato G., Nobile-Orazio E. Lumbosacral root and facial nerve enhancement in Miller Fisher syndrome. J Neurol. 1998 Nov;245(11):753–754. doi: 10.1007/s004150050282. [DOI] [PubMed] [Google Scholar]
- Rossini P. M., Pauri F. Central motor conduction time studies. Electroencephalogr Clin Neurophysiol Suppl. 1999;51:199–211. [PubMed] [Google Scholar]
- Sauron B., Bouche P., Cathala H. P., Chain F., Castaigne P. Miller Fisher syndrome: clinical and electrophysiologic evidence of peripheral origin in 10 cases. Neurology. 1984 Jul;34(7):953–956. doi: 10.1212/wnl.34.7.953. [DOI] [PubMed] [Google Scholar]
- Sumner A. J. The physiological basis for symptoms in Guillain-Barré syndrome. Ann Neurol. 1981;9 (Suppl):28–30. doi: 10.1002/ana.410090706. [DOI] [PubMed] [Google Scholar]
- Sumner A., Said G., Idy I., Metral S. Syndrome de Guillain-Barré. Effets électrophysiologiques et morphologiques du sérum humain introduit dans l'espace endoneural du nerf sciatique du rat. Résultats préliminaires. Rev Neurol (Paris) 1982;138(1):17–24. [PubMed] [Google Scholar]
- Taphoorn M. J., Uitdehaag B. M., Lanting P. A brain-stem lesion in the Miller Fisher syndrome demonstrated by CT and MRI. J Neurol. 1991 Jul;238(4):243–243. doi: 10.1007/BF00314791. [DOI] [PubMed] [Google Scholar]
- Uncini A., Lugaresi A. Fisher syndrome with tetraparesis and antibody to GQ1b: evidence for motor nerve terminal block. Muscle Nerve. 1999 May;22(5):640–644. doi: 10.1002/(sici)1097-4598(199905)22:5<640::aid-mus14>3.0.co;2-#. [DOI] [PubMed] [Google Scholar]
- Urushitani M., Udaka F., Kameyama M. Miller Fisher-Guillain-Barré overlap syndrome with enhancing lesions in the spinocerebellar tracts. J Neurol Neurosurg Psychiatry. 1995 Feb;58(2):241–243. doi: 10.1136/jnnp.58.2.241. [DOI] [PMC free article] [PubMed] [Google Scholar]
- van der Meché F. G., Visser L. H., Jacobs B. C., Endtz H. P., Meulstee J., van Doorn P. A. Guillain-Barré syndrome: multifactorial mechanisms versus defined subgroups. J Infect Dis. 1997 Dec;176 (Suppl 2):S99–102. doi: 10.1086/513779. [DOI] [PubMed] [Google Scholar]
